The WACC of PCC Rokita SA (PCR.WA) is 10.1%.
Range | Selected | |
Cost of equity | 10.2% - 14.4% | 12.3% |
Tax rate | 13.1% - 15.6% | 14.35% |
Cost of debt | 4.9% - 6.7% | 5.8% |
WACC | 8.4% - 11.8% | 10.1% |
Category | Low | High |
Long-term bond rate | 5.5% | 6.0% |
Equity market risk premium | 6.3% | 7.3% |
Adjusted beta | 0.74 | 1.07 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 10.2% | 14.4% |
Tax rate | 13.1% | 15.6% |
Debt/Equity ratio | 0.43 | 0.43 |
Cost of debt | 4.9% | 6.7% |
After-tax WACC | 8.4% | 11.8% |
Selected WACC | 10.1% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
PCR.WA | PCC Rokita SA | 0.43 | 0.47 | 0.34 |
ACT.DE | AlzChem Group AG | 0.04 | 0.49 | 0.47 |
CAR.L | Carclo PLC | 1.39 | 0.81 | 0.37 |
DYOBY.IS | DYO Boya Fabrikalari Sanayi ve Ticaret AS | 0.46 | 1.12 | 0.8 |
ELM.L | Elementis PLC | 0.26 | 1.12 | 0.92 |
NTG.DE | Nabaltec AG | 0.66 | 0.64 | 0.41 |
POLHO.IS | Polisan Holding AS | 0.29 | 1.04 | 0.83 |
SCPA.L | Scapa Group PLC | 0.23 | 1.55 | 1.3 |
SEFER.PA | Sergeferrari Group SA | 2.23 | 0.83 | 0.29 |
TET.L | Treatt PLC | 0.02 | 1.08 | 1.07 |
Low | High | |
Unlevered beta | 0.44 | 0.81 |
Relevered beta | 0.61 | 1.1 |
Adjusted relevered beta | 0.74 | 1.07 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for PCR.WA:
cost_of_equity (12.30%) = risk_free_rate (5.75%) + equity_risk_premium (6.80%) * adjusted_beta (0.74) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.